PhRMA published comments on CMS's proposed rule implementing the Inflation Reduction Act's Medicare Drug Price Negotiation Program.
Published
Signal category
Legal & Regulatory
Quote
“CMS wants to treat them as the same drug”
— Jocelyn Ulrich, MPH|PhRMA team
Company
PhRMA
Research. Progress. Hope.
- Industry
- Pharmaceutical Manufacturing
- Location
- Washington, US
- Company size
- 745 employees
We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments. PhRMA is committed to working with stakeholders in Washington, across the country and around the world to: 🔹Expand patient access to safe and effective medicines through a free market, without price controls 🔹Protect strong intellectual property incentives 🔹Promote transparent, effective regulation and a free flow of information to patients We’re building a policy environment where science can thrive, patients can benefit and cures can exist.
Founded 1958